-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, Ch2ESxK3+gYQIvFaydrvQQq5qtQ4ID88m07wtiekYPowIjyncQ4DViJ2A+DbhuLc vYHoD2ppioIGkFHemckHig== 0000875320-07-000111.txt : 20071119 0000875320-07-000111.hdr.sgml : 20071119 20071119145439 ACCESSION NUMBER: 0000875320-07-000111 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20071116 FILED AS OF DATE: 20071119 DATE AS OF CHANGE: 20071119 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: VERTEX PHARMACEUTICALS INC / MA CENTRAL INDEX KEY: 0000875320 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 043039129 STATE OF INCORPORATION: MA FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 130 WAVERLY STREET CITY: CAMBRIDGE STATE: MA ZIP: 02139-4242 BUSINESS PHONE: 6165776000 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: GARRISON RICHARD C CENTRAL INDEX KEY: 0001256466 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-19319 FILM NUMBER: 071256004 MAIL ADDRESS: STREET 1: 337 MARLBOROUGH STREET 3 CITY: BOSTON STATE: MA ZIP: 02115 4 1 edgar.xml PRIMARY DOCUMENT X0202 4 2007-11-16 0000875320 VERTEX PHARMACEUTICALS INC / MA VRTX 0001256466 GARRISON RICHARD C C/O VERTEX PHARMACEUTICALS INCORPORATED 130 WAVERLY STREET CAMBRIDGE MA 02139 0 1 0 0 SVP, Catalyst Common Stock 2007-11-16 4 S 0 62 25.82 D 21939 D Common Stock 2007-11-16 4 S 0 126 25.83 D 21813 D Common Stock 2007-11-16 4 S 0 62 25.93 D 21751 D Common Stock 2007-11-16 4 S 0 63 25.95 D 21688 D Common Stock 2007-11-16 4 S 0 63 25.96 D 21625 D Common Stock 2007-11-16 4 S 0 62 25.97 D 21563 D Common Stock 2007-11-16 4 S 0 63 26.05 D 21500 D Common Stock 2007-11-16 4 S 0 63 26.10 D 21437 D Common Stock 2007-11-16 4 S 0 63 26.16 D 21374 D Common Stock 628 I 401(k) Transaction made pursuant to Mr. Garrison's company approved trading plan established under Rule 10b5-1. Valerie L. Andrews, Attorney-In-Fact 2007-11-19 -----END PRIVACY-ENHANCED MESSAGE-----